These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35098906)
1. Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature. Decruyenaere P; Mazure D; Moors I; Van Dorpe J; Van der Linden M; Denys B; Hofmans M; Offner F Acta Clin Belg; 2023 Feb; 78(1):58-66. PubMed ID: 35098906 [TBL] [Abstract][Full Text] [Related]
2. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Wang SA; Hutchinson L; Tang G; Chen SS; Miron PM; Huh YO; Jones DM; Bueso-Ramos C; Verstovsek S; Medeiros LJ; Miranda RN Am J Hematol; 2013 Mar; 88(3):219-24. PubMed ID: 23440662 [TBL] [Abstract][Full Text] [Related]
3. Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases. Shah S; Pardanani A; Elala YC; Lasho TL; Patnaik MM; Reichard KK; Hanson CA; Ketterling RP; Tefferi A Am J Hematol; 2018 Dec; 93(12):1461-1466. PubMed ID: 30152525 [TBL] [Abstract][Full Text] [Related]
5. Systemic Mastocytosis: Advances in Diagnosis and Current Management. Pullarkat ST; Wu W; Pullarkat V Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361 [TBL] [Abstract][Full Text] [Related]
6. Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Pardanani A Am J Hematol; 2019 Mar; 94(3):363-377. PubMed ID: 30536695 [TBL] [Abstract][Full Text] [Related]
7. Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management. Pardanani A Am J Hematol; 2021 Apr; 96(4):508-525. PubMed ID: 33524167 [TBL] [Abstract][Full Text] [Related]
8. Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis. Naumann N; Jawhar M; Schwaab J; Kluger S; Lübke J; Metzgeroth G; Popp HD; Khaled N; Horny HP; Sotlar K; Valent P; Haferlach C; Göhring G; Schlegelberger B; Meggendorfer M; Hofmann WK; Cross NCP; Reiter A; Fabarius A Genes Chromosomes Cancer; 2018 May; 57(5):252-259. PubMed ID: 29341334 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid Leukemia with Hwang SM; Kim BJ; Lee JS; Seong MW; Seo SH; Paik JH; Kim SA; Lee JY; Lee JO; Chang YH; Bang SM Ann Lab Med; 2022 Nov; 42(6):678-682. PubMed ID: 35765876 [TBL] [Abstract][Full Text] [Related]
10. Systemic Mastocytosis with Associated Hematological Neoplasms. Diagnostic features and unique response pattern to tyrosine kinase inhibitors and allo-bone marrow transplantation therapy. Hernández Alconchel I; González de Villambrosía S; Insunza Gaminde A; Montes Moreno S Rev Esp Patol; 2023; 56(3):180-185. PubMed ID: 37419556 [TBL] [Abstract][Full Text] [Related]
11. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278 [TBL] [Abstract][Full Text] [Related]
12. Mast Cell Sarcoma of the Retroperitoneum With Concurrent Systemic Mastocytosis and an Undisclosed Associated Hematologic Neoplasm: A Case Report. Chen I; Liao JB; Lin JC; Hsieh PP; Hsieh MY Clin Pathol; 2022; 15():2632010X221123539. PubMed ID: 36119438 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis. Kluin-Nelemans HC; Jawhar M; Reiter A; van Anrooij B; Gotlib J; Hartmann K; Illerhaus A; Oude Elberink HNG; Gorska A; Niedoszytko M; Lange M; Scaffidi L; Zanotti R; Bonadonna P; Perkins C; Elena C; Malcovati L; Shoumariyeh K; von Bubnoff N; Müller S; Triggiani M; Parente R; Schwaab J; Kundi M; Fortina AB; Caroppo F; Brockow K; Zink A; Fuchs D; Angelova-Fischer I; Yavuz AS; Doubek M; Mattsson M; Hagglund H; Panse J; Simonowski A; Sabato V; Schug T; Jentzsch M; Breynaert C; Várkonyi J; Kennedy V; Hermine O; Rossignol J; Arock M; Valent P; Sperr WR Theranostics; 2021; 11(1):292-303. PubMed ID: 33391475 [TBL] [Abstract][Full Text] [Related]
14. Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia condition. Panda D; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Sardana R; Chaturvedi A; Rajpal S; Shetty D; Patkar NV; Gujral S; Subramanian PG; Tembhare PR Cytometry B Clin Cytom; 2021 May; 100(3):331-344. PubMed ID: 32738100 [TBL] [Abstract][Full Text] [Related]
15. Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review. Barozzi E; Bucelli C; Grifoni FI; Gianelli U; Iurlo A; Cattaneo D Front Oncol; 2021; 11():819097. PubMed ID: 35096623 [TBL] [Abstract][Full Text] [Related]
16. A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study. Wang X; Zhang L; Zhou D; Cai H; Wang X; Jiang X Medicine (Baltimore); 2020 Dec; 99(50):e21948. PubMed ID: 33327223 [TBL] [Abstract][Full Text] [Related]
17. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management. Pardanani A Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759 [TBL] [Abstract][Full Text] [Related]
18. A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases. Grifoni FI; Sciumè M; Pravettoni V; Ulivieri FM; Muratori S; Fracchiolla NS; Tagliaferri E; Gianelli U; Migliorini AC; Cro L; Pacilli A; Mannelli F; Baldini L Hematol Oncol; 2019 Apr; 37(2):205-211. PubMed ID: 30849188 [TBL] [Abstract][Full Text] [Related]
19. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369 [TBL] [Abstract][Full Text] [Related]
20. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]